https://www.selleckchem.com/pr....oducts/Ml-133-hcl.ht
It is unlikely that cases clinically diagnosed with ISS are caused by IDs leading to growth failure.Objectives Both CYP24A1 and SLC34A1 gene mutations are responsible for idiopathic infantile hypercalcemia, whereas loss-of-function mutations in CYP24A1 (25-OH-vitamin D-24-hydroxylase) lead to a defect in the inactivation of active 1.25(OH)2D; mutations in SLC34A1 encoding renal sodium phosphate cotransporter NaPi-IIa lead to primary renal phosphate wasting combined with an inappropriate activation of vitamin D. The presence of mutati
Like
Comment
Share
